Involvement of the proteasome in activation of endothelial nitric oxide synthase

Life Sciences

Volumn 73, Issue 17, 2003, Pages 2225-2236

  Govers, Roland ^a,b   De Bree, Petra ^a   Rabelink, Ton J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

DAF 2; Endothelium; eNOS; MG132 clasto lactacystin lactone; Proteasome

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CAVEOLIN 1; LACTACYSTIN; NITRIC OXIDE SYNTHASE; PROTEASOME;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SYNTHESIS; HEART CELL CULTURE; INTRACELLULAR SPACE; NONHUMAN; PROTEIN PROTEIN INTERACTION;

EID: 0041589368     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00644-1     Document Type: Article

References (54)

1. Andries L.J., Brutsaert D.L., Sys S.U. Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circulation Research. 82:1998;195-203.
2. Arnal J.F., Munzel T., Venema R.C., James N.L., Bai C.L., Mitch W.E., Harrison D.G. Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. Journal of Clinical Investigation. 95:1995;2565-2572.
3. Belhassen L., Feron O., Kaye D.M., Michel T., Kelly R.A. Regulation by cAMP of post-translational processing and subcellular targeting of endothelial nitric-oxide synthase (type 3) in cardiac myocytes. Journal of Biological Chemistry. 272:1997;11198-11204.
4. Bender A.T., Demady D.R., Osawa Y. Ubiquitination of neuronal nitric-oxide synthase in vitro and in vivo. Journal of Biological Chemistry. 275:2000;17407-17411.
5. Blair A., Shaul P.W., Yuhanna I.S., Conrad P.A., Smart E.J. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. Journal of Biological Chemistry. 274:1999;32512-32519.
6. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proceedings of the National Academy of Sciences of the USA. 87:1990;682-685.
7. Bucci M., Gratton J.P., Rudic R.D., Acevedo L., Roviezzo F., Cirino G., Sessa W.C. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nature Medicine. 6:2000;1362-1367.
8. Buckley B.J., Mirza Z., Whorton A.R. Regulation of Ca(2+)-dependent nitric oxide synthase in bovine aortic endothelial cells. American Journal of Physiology. 269:1995;C757-C765.
9. Casino P.R., Kilcoyne C.M., Quyyumi A.A., Hoeg J.M., Panza J.A. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 88:1993;2541-2547.
10. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., Pober J.S., Wick T.M., Konkle B.A., Schwartz B.S., Barnathan E.S., McCrae K.R., Hug B.A., Schmidt A.M., Stern D.M. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 91:1998;3527-3561.
11. Conner E.M., Brand S., Davis J.M., Laroux F.S., Palombella V.J., Fuseler J.W., Kang D.Y., Wolf R.E., Grisham M.B. Proteasome inhibition attenuates nitric oxide synthase expression, VCAM- 1 transcription and the development of chronic colitis. Journal of Pharmacology and Experimental Therapy. 282:1997;1615-1622.
12. Conrad P.A., Smart E.J., Ying Y.S., Anderson R.G., Bloom G.S. Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps. Journal of Cell Biology. 131:1995;1421-1433.
13. Dedio J., König P., Wohlfart P., Schroeder C., Kummer W., Müller-Esterl W. NOSIP, a novel modulator of endothelial nitric oxide synthase activity. Faseb Journal. 15:2001;79-89.
14. Felley-Bosco E., Bender F.C., Courjault-Gautier F., Bron C., Quest A.F. Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. Proceedings of the National Academy of Sciences of the USA. 97:2000;14334-14339.
15. Fischer S., Clauss M., Wiesnet M., Renz D., Schaper W., Karliczek G.F. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. American Journal of Physiology. 276:1999;C812-C820.
16. Fleming I., Busse R. Signal transduction of eNOS activation. Cardiovascular Research. 43:1999;532-541.
17. Fleming I., Fisslthaler B., Dimmeler S., Kemp B.E., Busse R. Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circulation Research. 88:2001;E68-E75.
18. Fulton D., Fontana J., Sowa G., Gratton J.P., Lin M., Li K.X., Michell B., Kemp B.E., Rodman D., Sessa W.C. Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme. Journal of Biological Chemistry. 277:2002;4277-4284.
19. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., Sessa W.C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 399:1999;597-601.
20. Garcia-Cardeña G., Oh P., Liu J., Schnitzer J.E., Sessa W.C. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proceedings of the National Academy of Sciences of the USA. 93:1996;6448-6453.
21. Ghigo D., Alessio P., Foco A., Bussolino F., Costamagna C., Heller R., Garbarino G., Pescarmona G.P., Bosia A. Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cells. American Journal of Physiology. 265:1993;C728-C732.
22. Ghigo D., Arese M., Todde R., Vecchi A., Silvagno F., Costamagna C., Dong Q.G., Alessio M., Heller R., Soldi R. Middle T antigen-transformed endothelial cells exhibit an increased activity of nitric oxide synthase. Journal of Experimental Medicine. 181:1995;9-19.
23. Govers R., ten Broeke T., van Kerkhof P., Schwartz A.L., Strous G.J. Identification of a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth hormone receptor. EMBO Journal. 18:1999;28-36.
24. Govers R., Rabelink T.J. Cellular regulation of endothelial nitric oxide synthase. American Journal of Physiology. 280:2001;F193-F206.
25. Govers R., Bevers L., de Bree P., Rabelink T.J. Endothelial nitric oxide synthase activity is linked to its presence at cell-cell contacts. Biochemical Journal. 361:2002;193-201.
26. Govers R., van der Sluijs P., van Donselaar E., Slot J.W., Rabelink T.J. Endothelial nitric oxide synthase and its negative regulator caveolin-1 localize to distinct perinuclear organelles. Journal of Histochemistry and Cytochemistry. 50:2002;779-788.
27. Griscavage J.M., Wilk S., Ignarro L.J. Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. Proceedings of the National Academy of Sciences of the USA. 93:1996;3308-3312.
28. Hershko A. Roles of ubiquitin-mediated proteolysis in cell cycle control. Current Opinion in Cell Biology. 9:1997;788-799.
29. Hershko A., Ciechanover A. The ubiquitin system. Annual Review of Biochemistry. 67:1998;425-479.
30. Jaffrey S.R., Snyder S.H. PIN: an associated protein inhibitor of neuronal nitric oxide synthase. Science. 274:1996;774-777.
31. Ju H., Zou R., Venema V.J., Venema R.C. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. Journal of Biological Chemistry. 272:1997;18522-18525.
32. Kojima H., Nakatsubo N., Kikuchi K., Kawahara S., Kirino Y., Nagoshi H., Hirata Y., Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Analytical Chemistry. 70:1998;2446-2453.
33. Lee M.H., Hyun D.H., Jenner P., Halliwell B. Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. Journal of Neurochemistry. 78:2001;32-41.
34. Liu J., Garcia-Cardeña G., Sessa W.C. Biosynthesis and palmitoylation of endothelial nitric oxide synthase: mutagenesis of palmitoylation sites, cysteines-15 and/or -26, argues against depalmitoylation-induced translocation of the enzyme. Biochemistry. 34:1995;12333-12340.
35. Liu J., Garcia-Cardeña G., Sessa W.C. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry. 35:1996;13277-13281.
36. Marrero M.B., Venema V.J., Ju H., He H., Liang H.Y., Caldwell R.B., Venema R.C. Endothelial nitric oxide synthase interactions with G- protein-coupled receptors. Biochemical Journal. 343:1999;335-340.
37. Mellion B.T., Ignarro L.J., Ohlstein E.H., Pontecorvo E.G., Hyman A.L., Kadowitz P.J. Evidence for the inhibitory role of guanosine 3′, 5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 57:1981;946-955.
38. Michel J.B., Feron O., Sacks D., Michel T. Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. Journal of Biological Chemistry. 272:1997;15583-15586.
39. Michell B.J., Harris M.B., Chen Z.P., Ju H., Venema V.J., Blackstone M.A., Huang W., Venema R.C., Kemp B.E. Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serines 617 and 635. Journal of Biological Chemistry. 277:2002;42344-42351.
40. Montesano R., Pepper M.S., Mohle-Steinlein U., Risau W., Wagner E.F., Orci L. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell. 62:1990;435-445.
41. Musial A., Eissa N.T. Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. Journal of Biological Chemistry. 276:2001;24268-24273.
42. Nakatsubo N., Kojima H., Kikuchi K., Nagoshi H., Hirata Y., Maeda D., Imai Y., Irimura T., Nagano T. Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diaminofluoresceins. FEBS Letters. 427:1998;263-266.
43. Orian A., Whiteside S., Israel A., Stancovski I., Schwartz A.L. Ubiquitin-mediated processing of NF-kappa B transcriptional activator precursor p105 - Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation. Journal of Biological Chemistry. 270:1995;21707-21714.
44. Radomski M.W., Palmer R.M., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 2:1987;1057-1058.
45. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78:1994;761-771.
46. Sakoda T., Hirata K., Kuroda R., Miki N., Suematsu M., Kawashima S., Yokoyama M. Myristoylation of endothelial cell nitric oxide synthase is important for extracellular release of nitric oxide. Molecular and Cellular Biochemistry. 152:1995;143-148.
47. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
48. Stan R.V., Roberts W.G., Predescu D., Ihida K., Saucan L., Ghitescu L., Palade G.E. Immunoisolation and partial characterization of endothelial plasmalemmal vesicles (caveolae). Molecular Biology of the Cell. 8:1997;595-605.
49. Taddei S., Virdis A., Ghiadoni L., Magagna A., Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation. 97:1998;2222-2229.
50. Tanner F.C., Meier P., Greutert H., Champion C., Nabel E.G., Luscher T.F. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation. 101:2000;1982-1989.
51. Tsubuki S., Saito Y., Kawashima S. Purification and characterization of an endogenous inhibitor specific to the Z-Leu-Leu-Leu-MCA degrading activity in proteasome and its identification as heat-shock protein 90. FEBS Letters. 344:1994;229-233.
52. Wiertz E.J.H.J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T.R., Rapoport T.A., Ploegh H.L. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature. 384:1996;432-438.
53. Williams S.B., Cusco J.A., Roddy M.A., Johnstone M.T., Creager M.A. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. Journal of the American College of Cardiologists. 27:1996;567-574.
54. Xia Y., Tsai A.L., Berka V., Zweier J.L. Superoxide generation from endothelial nitric-oxide synthase - A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. Journal of Biological Chemistry. 273:1998;25804-25808.